BCYC Insider Trading Activity and SEC Form 4 Filings
BCYC insider trading summary
Over the past 12 months, insiders at Bicycle Therapeutics PLC (BCYC) reported 49 sales worth $523K by 8 insiders and no open-market purchases on SEC Form 4. Net insider selling was $523K.
Latest BCYC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Jennifer Scott Perry | Chief Operating Officer | Sell | $107 (30 @ $3.57) |
| Oct 5, 2026 | Kevin Lee | Chief Executive Officer | Sell | $6K (1,638 @ $3.57) |
| Oct 5, 2026 | Michael Skynner | Chief Scientific Officer | Sell | $2K (503 @ $3.57) |
| Oct 5, 2026 | Michael Charles Ferguson Hannay | Chief Prod & Supply Chain Off | Sell | $864 (242 @ $3.57) |
| Oct 5, 2026 | Travis Alvin Thompson | Chief Financial Officer | Sell | $282 (79 @ $3.57) |
| Oct 5, 2026 | Jennifer Scott Perry | Chief Operating Officer | Sell | $1K (326 @ $3.78) |
| Oct 5, 2026 | Jennifer Scott Perry | Chief Operating Officer | Sell | $1K (326 @ $3.78) |
| Oct 5, 2026 | Jennifer Scott Perry | Chief Operating Officer | Sell | $285 (80 @ $3.56) |
| Oct 2, 2026 | Jennifer Scott Perry | Chief Operating Officer | Sell | $4K (1,094 @ $3.47) |
| Oct 2, 2026 | Michael Skynner | Chief Scientific Officer | Sell | $7K (1,942 @ $3.47) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.